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 PREFACE 
The emergency room is one of the few settings in the health system of the United states, 
where there is a lot of interaction between healthcare services and members of the society, 
especially those that are socio-economically limited to accessing extensive health services. 
These interactions makes the emergency room an ideal setting for collecting and analyzing 
health-related data. Although there is a lot of parameters that can be feasibly studied and 
analyzed, even with basic statistics, yet, several systems of collecting data are not 
supplemented with suitable analyses. My primary motivation for this thesis is to contribute to 
the effort of bridging the gap between the knowledge that is embedded in data that have not 
been analyzed and the evidence basis for medical practice. 
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Table 1: Demographic characteristics, hospital system, and primary diagnosis for patients’ first emergency department visit resulting in testing for syphilis, chlamydia/gonorrhea and HIV in four North 
Texas counties (N=20,809) 
Syphillis P-Val HIV P-Val Chlamydia/Gonorrhea P-Val 
 Not Tested  
16,768 (80.6%) 
 Tested  
4041 (19.4%) 
 
<0.001 
Not Tested  
18,031 (86.7%) 
 Tested  
2778 (13.3%) 
 
<0.001 
Not Tested  
12,131 (58.3%) 
 Tested  
8,678 (41.7%) 
 
<0.001 
Age   0.0166   0.074   0.0002 
    0-17 798 (4.8%) 159 (3.9%)  849 (4.7%) 108 (3.9%)  501 (4.1%) 456 (5.3%)  
    18-44 15928 (95%) 3867 (95.7%)  17,137 (95%) 2,658 (95.7%)  11,588 (95.5%) 8,207 (94.6%)  
    45-64 42 (0.25%) 14 (0.4%)  44 (0.2%) 12 (0.4%)  41 (0.3%) 15 (0.2%)  
    65+ 0 (0.0%) 1 (<0.1%)  1 (<0.1%) 0 (0.0%)  1 (<0.1%) 0 (0.0%)  
Gender 
(female) 
16768 (80.6%) 4041 (19.4%) 1 18,031 (86.7%) 4041 (19.4%) 1 12,131 (58.3%) 8,678 (41.7%) 1 
Race/Ethnicity   <0.001   <0.001   <0.001 
   Non-Hispanic 
White  
9091 (54.22%) 2674 (66.1%)  10,034 (55.7%) 1,731 (62.3%)  7,857 (64.8%) 3,908 (45%)  
   Non-Hispanic 
Black  
5132 (30.6%) 969 (24.0%)  5,398 (29.9%) 703 (25.3%)  2,750 (22.7%) 3,351 (38.6%)  
    Other 2545 (15.2%) 398 (9.9%)  2,599 (14.1%) 344 (12.4%)  1,524 (14.1%) 1,419 (16.4%)  
Insurance   <0.001   <0.001   <0.001 
    Private 2611 (15.6%) 347 (8.59%)  2,776 (15.4%) 182 (6.6%)  1,200 (9.9%) 1,758 (20.3%)  
iii 
 
    
Medicaid/Medi
care 
7281 (43.4%) 2283 (56.5%)  8,041 (44.6%) 1,523 (54.8%)  5,949 (49.0%) 3,615 (41.7%)  
    Other 269 (1.6%) 38 (0.9%)  244 (1.4%) 63 (2.3%)  179 (1.5%) 128 (1.5%)  
    Unknown 
(Self-pay, 
charity)  
6607 (39.4%) 1373 (34.0%)  6,970 (38.7%) 1,010 (36.4%)  4,803 (39.6%) 3,177 (36.6%)  
Patient’s 
county of 
residence 
  <0.001      <0.001 
    Dallas 10484 (62.5%) 3481 (86.1%)  11,749 (62.5%) 2,216 (86.1%)  9,668 (79.7%) 4,297 (49.5%)  
    Denton 1067 (6.4%) 121 (3.0%)  1,134 (6.3%) 54 (1.9%)  653 (5.4%) 535 (6.2%)  
    Tarrant 5217 (31%) 439 (10.9%)  5,148 (31%) 508 (18.3%)  1,810 (14.9%) 3,846 (44.3%)  
Hospital county   <0.001   <0.001   <0.001 
    Dallas 9981 (59.5%) 3455 (85.50%)  11,232 (62.3%) 2,204 (79.3%)  9,579 (79.0%) 2,204 (79.3%)  
    Denton 1150 (6.8%) 96 (2.4%)  1,201(6.8%) 45 (1.6%)  618 (5.1%) 628 (7.2%)  
    Tarrant 5241 (31.3%) 442 (10.9%)  5,187 (28.8%) 496 (17.9%)  1,774 (14.6%) 3,909 (45.0%)  
    Collin 163 (1%) 27 (0.7%)  179 (1%) 11 (0.4%)  90 (0.7%) 100 (1.2%)  
    Other (Ellis, 
Erath, Grayson, 
233 (1.4%) 21 (0.5%)  232 (1.3%) 22 (0.8%)  70 (0.6%) 184 (2.1%)  
iv 
 
Hunt, Johnson, 
Kaufman, 
Rockwall, and 
Wise) 
Hospital system   <0.001   <0.001   <0.001 
    County 
Safety Net 
7746 (46.2%) 3426 (84.8%)  8674 (48.1%) 2498 (89.9%)  9586 (79.0%) 1586 (18.3%)  
    For Profit   1617 (9.65%) 254 (6.3%)  1825 (10.1%) 46 (1.7%)  1428 (76.3%) 443 (5.1%)  
    Faith Based 
NFP 
2337 (13.94%) 107 (2.7%)  2420 (13.4%) 24 (0.9%)  252 (2.1%) 2192 (25.3%)  
    Not for 
Profit 
5063 (0.5%) 253 (6.3%)  5106 (28.3%) 210 (7.6%)  864 (7.1%) 4452 (51.3%)  
Primary 
diagnosis for 
emergency 
department 
visit 
  <0.001   <0.001   <0.001 
   Abortion 5313 (31.7%) 662(16.4%)  5,454 (30.3%) 521(18.8%)  2,773 22.9%) 3,202 (36.9%)  
   
Cardiovascular  
65 (0.4%) 249 (6.2%)  214 (1.2%) 100 (3.6%)  276 (2.3%) 38 (0.44%)  
v 
 
   CNS 20 (0.1%) 17 (0.4%)  26 (0.1%) 11 (0.4%)  25 (0.2%) 12 (0.1%)  
   GI 655 (3.9%) 134 (3.3%)  675 (3.8%) 114 (4.1%)  434 (3.6%) 355 (4.1%)  
   Heme 5 (0.03%) 4 (0.1%)  6 (0.0%) 3 (0.1%)  6 (0.1%) 3 ((<0.1%)  
   Infectious 
Disease 
Syphi
lis 
Chla
mydi
a 
Gono
rrhea 
STI – 
Other
s 
GU/
UTI 
Puerp
eral 
 
4 (0.02%) 
2 (0.01%) 
19 (0.11%)  
98 (0.58%) 
2829 (16.88%) 
18 (0.11%) 
281 (1.68%) 
 
6 (0.15%) 
0 (0.00%) 
0 (0.00%) 
6 (0.15%) 
190 (4.71%) 
0 (0%) 
37 (0.92%) 
  
5 (0.03%) 
2 (0.01%)  
 
19 (0.11%) 
 
100 (0.55%) 
 
2837 (15.74%) 
 
17 (0.09%) 
 
287 (1.59%) 
 
5 (0.18%) 
0 (0.00%) 
0 (0.00%) 
4 (0.14%) 
182 (6.57%) 
1 (0.04%) 
318 (0.14%) 
  
7 (0.06%) 
2 (0.02%) 
12 (0.10%) 
70 (0.58%) 
1319 (10.88%) 
6 (0.05%) 
160 (1.32%) 
 
3 (0.03%) 
0 (0.00%) 
7 (0.08%) 
34 (0.39%) 
1700 (19.60%) 
12 (0.14%) 
158 (1.82%) 
 
vi 
 
 
  
Other 
ID 
   Metabolic  160 (1.0%) 138 (3.4%)  182 (1.0%) 116 (4.2%)  255 (2.1%) 43 (0.5%)  
   Misc 35 (0.2%) 12 (0.3%)  38 (0.2%) 9 (0.3%)  29 (0.2%) 18 (0.2%)  
   
Musculoskeleta
l 
6 (0.0%) 3 (0.1%)  7 (0.0%) 2 (0.1%)  7 (0.1%) 2 ((<0.1%)  
   Pregnancy 
Complications 
7190 (42.9%) 2553 (63.3%)  8,098 (44.9%) 1,645 (59.4%)  6,670 (55.0%) 3,073 (35.4%)  
   Psychiatric 47 (0.3%) 20 (0.5%)  42 (0.2%) 25 (0.9%)  59 (0.5%) 8 (0.1%)  
   Renal 7 (0.04%) 2 (0.1%)  7 (0.0%) 2 (0.1%)  6 (0.1%) 3 ((<0.1%)  
   Respiratory 8 (0.1%) 0 (0.0%)  8 (0.1%) 0 (0.0%)  4 ((<0.1%) 0 (0.0%)  
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BACKGROUND  
 
Literature Review 
Following an initial decrease in the incidence of congenital syphilis from 2008-2012, 
the rate of congenital syphilis rose by 38% across the United States between 2012-2014 (2). 
This trend followed a 22% rise in primary and secondary syphilis cases in women during the 
same period.(1) Vertical transmission of syphilis is a significant public health concern, 
contributing to stillbirth, infant mortality, and neurologic and skeletal morbidities in 
survivors. (2) The Centers for Disease Control and Prevention (CDC) recommends that all 
pregnant women be screened for sexually transmitted infections (STI) including HIV, 
syphilis, and hepatitis B at the first prenatal visit regardless of prior testing. The American 
College of Obstetricians and Gynecologists (ACOG) and the U.S. Preventive Services Task 
Force (USPSTF) also support similar recommendations. Yet, a CDC investigation into this 
epidemic revealed that 21% of women whose infants were diagnosed with congenital syphilis 
had no prenatal care, and of those who had at least one prenatal visit, 43% received no 
treatment for syphilis during pregnancy and 30% received inadequate treatment. (2, 3) 
Little is understood about factors associated with low STI screening during pregnancy 
in the US. In a 2014 study, Cha, et al. evaluated factors affecting the likelihood of STI 
screening in pregnant women in Guam. They found that the biggest barrier to STI testing was 
lack of prenatal care and insurance. Even women with access to prenatal care were not 
routinely screened for syphilis before 24 weeks’ gestation. Despite a 93.5% overall rate of 
screening for syphilis at any time during pregnancy, the authors found much lower screening 
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rates for other STIs, including 31% for HIV, 25.3% for chlamydia, and 25.7% for gonorrhea. 
(8) This suggests potential disparity in testing practices based on risk perception by providers 
or patients.  
Public Health Significance 
The emergency department (ED) presents public health opportunities to expand STI 
and syphilis screening. ED screening can help expand services to underinsured women, and 
represents a key point of entry into the health care system. (10) However, ED screening 
practices for STIs depend on a variety of factors, including requirements for pre and post-test 
counseling, ability to establish appropriate follow up,  disagreement regarding appropriate 
screening and diagnostic testing in an emergency setting,  perception of disease prevalence, 
and insurance coverage. (5, 10, 11) The annual National Hospital Ambulatory Medical Care 
Survey in 2009 from all 50 states and the District of Columbia reviewed STI screening 
practices in the emergency department and revealed that only 2.3% of patients who presented 
with symptoms of STIs, sexual abuse, or pregnancy, received any HIV testing. The survey 
also revealed that if ED staff perceived a low prevalence of HIV in their local population, 
then testing was less likely to be offered, and some practitioners questioned if HIV screening 
should even be performed in the emergency department where critical illnesses were a higher 
priority. (10) Another study found that among women with no prenatal care, 44% had visited 
emergency clinics and 33% of them were screened for syphilis, further demonstrating that the 
ED provides another potential opportunity for testing. (9) Outside the ED setting, a review of 
a U.S administrative claims database from 2009-2010 showed that 95% of pregnant patients 
with Medicaid or commercial insurance were tested for syphilis and hepatitis B. Furthermore, 
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prenatal HIV screening rates were higher in younger women (15-19 years of age) and in the 
southern United States. (6) This study suggests that testing for STIs varies between health 
care settings, from primary care offices to emergency departments, and is influenced by 
several factors including patient age and healthcare coverage. (11) Evaluating STI testing 
patterns in EDs located in high-prevalence areas could potentially identify opportunities for 
intervention. 
Hypothesis, Research Question, Specific Aims or Objectives 
Our aim was to examine population and individual-level factors associated with STI 
testing patterns in a metropolitan area in the South through claims-based data from the 
Dallas-Fort Worth Hospital Council.  
 
METHODS 
Data Collection 
The Dallas-Fort worth Hospital Council Education and Research Foundation 
(DFWHC) data warehouse is a repository of claims-based data from regional EDs in the 
DFW area of north Texas. Since 2000, the DFWHC data warehouse has stored healthcare 
data for approximately 10.7 million unique patients and 51 million hospital encounters. This 
warehouse collects ED claims data from 80% of the hospitals in North Texas. The DFWHC 
receives visit-centric data and establishes a regional enterprise master patient index (REMPI), 
which assigns a unique ID to all patients, allowing researchers to track patients over time.  
The data is submitted in a standardized format and processed through a data quality tool that 
ensures accuracy and normalizes the data.  The average data quality measurement for 
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participating facilities is 93%.  Critical errors require correction before the patient encounter 
can be entered into the database.  One example of a critical error would be an encounter 
missing the principal diagnosis code or having an invalid diagnosis code. The primary benefit 
of using the DFWHC data is the large sample size of the database, which provided a robust 
distribution for statistical analysis.  
Study Setting 
DFWHC data were extracted for all patients who visited an ED from July 2014 
through June 2015 and who had at least one of three STI tests (HIV, syphilis or combined 
GC/CT test) performed at the visit. Data were analyzed for EDs in Dallas, Tarrant, Collin, 
and Denton counties, which include the two major population centers, Dallas and Fort Worth. 
We limited this dataset to include women with a pregnancy-related diagnosis as defined by 
ICD-9 codes 630-676 (Appendix), and excluded any diagnosis associated with a past medical 
history of pregnancy or family history of pregnancy-related complications to limit inclusion 
to active pregnancy cases. We only examined claims for sexually transmitted infections that 
included HIV, syphilis or gonorrhea and chlamydia. Chlamydia (CT) and gonorrhea (GC) 
tests were combined, as the most common test used is the combined nucleic acid 
amplification test. HIV and syphilis screening was determined based on CPT codes. 
Study Design 
A cross-sectional study design. We reviewed the primary diagnoses (based on ICD-9 
codes) and other factors including race, insurance coverage, and geographic location 
(hospital county), to determine associations with STI testing.  Primary diagnoses were 
classified into the following categories: 1) early pregnancy loss or abortion-related, 2) 
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cardiovascular (including venous thrombosis and hypertension, 3) central nervous system 
(including headaches and seizures), 4) gastrointestinal, 5) hematologic, 6) infectious diseases 
(pertaining to genitourinary infections), 7) metabolic (related to glucose, thyroid, and bone 
disorders), 8) musculoskeletal, 9) pregnancy complications (other than early pregnancy loss 
or abortion-related), 10) psychiatric, 11) renal, 12) respiratory, and 13) miscellaneous.  
Study Subjects 
This study is considered a quality improvement study. Hence IRB approval was not 
required to carry out this study. We evaluated claims-based data on 123,834 women who 
visited north Texas emergency departments from 2014 to 2015 and were tested for a sexually 
transmitted infection during the visit. Of these, a total of 20,809 women (16.8%) with a 
pregnancy-related diagnosis were screened for HIV, syphilis, or gonorrhea and chlamydia. 
These women had a total of 26,416 recorded visits.  
Sample Size Calculation and/or Study Power 
 This is a retrospective study that is based on available data. No power computation 
was performed. 
 
Data Analysis 
Statistical Analysis was performed using SAS 9.4 ©  to conduct descriptive and 
inferential analyses on the data. We described the distribution of screening provided based on 
race, age, insurance coverage, hospital, geographic location, and primary diagnosis. The 
distributions and frequency were plotted using Tableau 2018.3.0© . We used the chi-square 
test for univariate analyses of categorical variables to test for association. Also, we 
performed a prevalence ratio estimation using the GENMOD procedure on SAS to model the 
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relationship between predictor variables: Hospital system, principal diagnosis, Hospital 
county, patient county, Primary payer, patient race, and patient group and response variable: 
Syphilis, HIV, Chalmydia and Gonorrhea testing patterns. For the models, Syphilis was used 
as a reference group among the principal diagnosis category, for-profit-organizations were 
used as the reference group for the hospital system category, Dallas was used as the reference 
group for the hospital county category, Tarrant county was used as the reference group for 
the patient’s county category, “Other’s insurance” which includes self-pay and commercial 
insurances were used as the reference group for the insurance category, “Other race”, which 
included Asian, and pacific American were used as the reference group for race, and the 
patient age group 0-17 years were used as the reference group for the age category. A p value 
of <0.05 was considered significant for all analyses.  
 
Human Subjects, Animal Subjects, or Safety Considerations  
This study was based on de-identified claims data. No human or animal subjects were 
involved. 
 
RESULTS 
Testing Patterns for Syphilis 
Of the total number of women meeting inclusion criteria, 19.4% were screened for 
syphilis. In the subset of 4036 patients screened for syphilis, 1630 women were screened for 
syphilis alone, 2,287 were screened for both syphilis and HIV, 32 were screened for syphilis, 
chlamydia and gonorrhea, and 92 were screened for syphilis, chlamydia, gonorrhea and HIV.  
Univariate analysis of factors associated with syphilis testing are shown in Table 1.  
The County safety prevalence ratio was 0.7103 (0.5554 0.8652), faith based not for profit 
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was  -0.5658 (-0.8051 -0.3265) and Not for profit was -1.0423 (-1.2272 -0.8573). Patient 
county of residence was estimated at a prevalence ratio for Dallas 0.4316 (0.1694 0.6939), 
and Denton 0.4811 (0.1123 0.8500). The other parameters did not show any significant 
difference in the parameters for testing for syphilis.  
Testing Patterns for HIV 
Of the 20,809 women who presented to north Texas emergency departments with a 
pregnancy-related diagnosis, 13.3% received screening tests for HIV. Univariate analysis of 
factors associated with HIV testing are shown in Table 1. The significant prevalence ratio 
were Abortion -1.2646 (-2.1486 -0.3806), and other STI -2.4227 (-3.7396 -1.1058). Faith 
based NFP was not significant. County safety was (2.5908 2.2524 2.9291), and NFP 0.8141 
(0.4736 1.1547).For insurance, Medicaid -0.4642 ( -0.7296 -0.1987), Private -0.6179 (-
0.9153 -0.3205) and unknown was -0.6936  (-0.9601 -0.4270). Patient race and patient age 
group were not significant. 
Testing Patterns for Chlamydia and Gonorrhea 
Of the 20,809 women who presented to north Texas emergency departments with a 
pregnancy-related diagnosis, 41.7% received screening tests for gonorrhea/chlamydia. 
Univariate analysis of factors associated with GC/CT testing are shown in Table 1.   There 
was no significant prevalence ratio among the principal diagnosis group testing for 
chlamydia and gonorrhea. There was a prevalence ratio of -0.319 (-0.5032, -0.2789) for 
county safety net testing for chlamydia and gonorrhea. There was prevalence ratio of  0.9972
 (0.8866 - 1.1077) for Faith based NFP, and a prevalence ratio of 1.4182 (1.3155, 
1.5208) for Not for profit hospital systems. Collin 0.2924 (0.0862, 0.4985), Denton 0.1749 
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(0.0478 0.3019), Others 0.7652 (0.6115 0.9188) Tarrant0.6951 (0.5743 0.8158). There were 
no significant difference in prevalence ratio among the patient county, primary insurance or 
patient age group. For patient race, black was -0.1623 (-0.2280 -0.0967) and non-Hispanic 
white was -0.3758 (-0.4385 -0.3130). 
 
Discussion  
After reviewing visit data for 20,809 women with a pregnancy-related diagnosis who 
accumulated 26,416 visits to north Texas emergency departments over a 12-month period 
and were screened for at least one STI, we determined three main findings. First, women 
with a pregnancy-related diagnosis who presented with a cardiovascular, metabolic, or CNS-
related complaint were more likely to be screened for syphilis compared to women who 
presented with symptoms of an infectious disease or potential abortion. The cardiovascular 
and CNS symptoms may implicate tertiary or neuro-syphilis as a risk factor and thus may 
have prompted testing, but metabolic symptoms are typically less associated with syphilis. In 
comparison, presentation with genitourinary infectious complaints and abortion can be 
indications of primary or secondary syphilis in the mother or congenital syphilis that can 
result in abortions. This paradoxical relationship with testing patterns and patient 
presentation warrants further exploration through in-depth chart reviews to determine what 
prompted providers to test for the same. It is also intriguing that pregnant women who 
presented with infectious complaints were more likely to receive GC/CT than HIV testing, 
considering that immunosuppression and consequent risk for infections is more linked with 
HIV than GC/CT. 
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Second, patient factors such as race and age appeared to affect rates of STI testing 
across north Texas emergency departments. White women were more likely to be screened 
for syphilis or HIV, which is in contrast to black women who were more likely to be 
screened for chlamydia and gonorrhea. Women less than 17 years were more likely to be 
screened for chlamydia and gonorrhea, compared to women aged 18-44 years who were 
more likely to be tested for syphilis, and women 45-64 years were more likely to be tested for 
HIV. These patterns may have been influenced by some epidemiologic profiles and 
guidelines that focus on gonorrhea/chlamydia testing in women under the age of 25. (4) In a 
review of Medicaid claims data looking at women 15-21 years of age and chlamydia 
screening rates, this showed that black women were screened more frequently, which is in 
concordance with our results. (12)  
Recommendations from the CDC, ACOG, and USPSTF are published to guide 
testing during pregnancy in order to reduce preventable causes of morbidity and mortality 
related to sexually transmitted infections to both the mother and child before and after birth. 
(2) Of these 20,809 women who were presumably considered at risk for an STI based on the 
fact that they were tested for either HIV, syphilis or GC/CT, 4,041 women received a sole 
syphilis test and 2,287 women received both syphilis and HIV testing at the same visit, 
compared to only 122 women who received syphilis and GC/CT testing and 90 women who 
had syphilis, GC/CT, and HIV testing. A retrospective review of pregnant women in an 
urban hospital revealed several factors that were missed opportunities for screening that 
resulted in congenital syphilis, one of which was women not being screened at the 
recommended trimester. (9) A study of HIV-infected pregnant women who underwent STI 
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screening, found lower rates of HIV transmission from mother-to-child in women without 
gonorrhea or chlamydia compared to HIV-infected pregnant women with one or both 
gonorrhea or chlamydia. Untreated infections not only have maternal complications, but can 
lead to preterm labor, conjunctivitis, disseminated disease, and even fetal loss. (5)  
 A 2015 CDC review of STI surveillance in both men and women in the United States 
revealed that the South (including Texas) had the highest number of cases of syphilis, 
chlamydia, and gonorrhea. (4) When further broken down in the north Texas area, Dallas 
county had higher rates of gonorrhea, chlamydia, and syphilis than Tarrant and Collin 
counties in 2015. (4) Although there were many missed opportunities as evidenced by the 
low rate of STI screening in pregnant women, this review allows us to evaluate specific data 
points as potential areas of improvement in STI testing patterns in the ED. In our dataset, 
hospitals in Dallas County had higher screening rates for syphilis and HIV, compared to 
hospitals in the neighboring Tarrant County (which serves the city of Fort Worth) who had 
higher rates of testing for chlamydia and gonorrhea. Such a trend may be explained by 
different practice cultures in individual health settings and may warrant further exploration 
through interaction with practice providers in both settings. 
There are some limitations to our approach. One limitation of this ED claims-based 
data analysis is the absence of specific diagnostic test results and treatment details outside of 
the ED setting, including from prenatal clinics. Laboratory testing results from ambulatory 
visits could be captured through in-depth electronic medical record (EMR) chart reviews. 
However, since the highest testing rates took place at county-funded safety net settings and 
utilization of routine health care is generally low for pregnant women who seek care at safety 
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net settings, we can capture healthcare utilization across a comprehensive geographic setting 
which is more challenging to do with individual hospital-based EMRs. While this data type 
cannot provide detailed information on the types of presenting symptoms outside of the 
codes used for claims, it does provide a population-level snapshot of patterns of care.  
Further study is needed to explore the specific trends that have emerged through provider 
surveys and in-depth chart reviews to identify potential causal associations driving these 
unique STI testing patterns in EDs. 
CONCLUSION  
The proportion of women screened for syphilis alone or in combination with other STIs was 
low among those with a pregnancy-related diagnosis who presented to emergency 
departments in the DFW region. Patient factors including race, age, and presenting 
symptoms, and hospital factors such as geographic location were associated with differences 
in STI screening patterns. 
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